Clinical Trial Update: Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating self-sampling and HPV testing for unscreened women to prevent cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Dysplasia

Snippet

Sponsor: University Hospital, Tours | Conditions: Uterine Cervical Neoplasms, Uterine Cervical Dysplasia | Phase 3 | Status: COMPLETED